The fight against TB has taken several promising steps forward – scientists from Rutgers University have not only uncovered vital new information about how rifampicin, the frontline anti-TB drug, binds to its target, but have also discovered a completely new class of compounds that specifically kill TB bacteria. The paper was published in the journal … Read more
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!